AboutInVivoPlusanti-mouseIL-17A
The17F3monoclonalantibodyreactswithmouseIL-17Aa15-20kDacytokineexpressedbyTh17cells,γδTcells,iNKTcells,NKcells,LTicells,neutrophils,andintestinalPanethcells.IL-17Ahaspleiotropiceffectsinimmunoregulationandinflammation.Itplaysanimportantroleinanti-microbialandchronicinflammationbyinducingcytokineandchemokineproduction,neutrophilinflux,andtheproductionofantibacterialpeptidesbutitisalsoaninflammatorymediatorinthedevelopmentofautoimmunediseasesincludingrheumatoidarthritis,asthma,multiplesclerosis,andpsoriasis.The17F3antibodyhasbeenshowntoneutralizeIL-17Ainvivo.
InVivoPlusanti-mouseIL-17ASpecifications
| Isotype | MouseIgG1, κ |
| RecommendedIsotypeControl(s) | InVivoPlusmouseIgG1isotypecontrol,unknownspecificity(BP0083) |
| RecommendedInVivoPureDilutionBuffer | InVivoPurepH7.0DilutionBuffer(IP0070) |
| Immunogen | MouseIL-17Across-linkedtoOVA |
| ReportedApplications |
|
| Endotoxin |
|
| Purity |
|
| Aggregation |
|
| Formulation |
|
| Sterility | 0.2µmfiltration |
| Production | Purifiedfromtissueculturesupernatantinananimalfreefacility |
| Purification | ProteinG |
| Storage | Theantibodysolutionshouldbestoredundilutedat4°C,andprotectedfromprolongedexposuretolight.Donotfreeze. |
| MurinePathogenTestResults |
|
| RRID | AB_10950102 |
